FindTrial
Sign In

Role of homoeopathy in Fibroid

HOMOEOPATHIC MANAGEMENT OF UTERINE FIBROID IN REPRODUCTIVE AGE GROUP USING THE RUBRIC FIBROID FROM MURPHYS REPERTORY AS ELIMINATING RUBRIC:A PROSPECTIVE OBSERVATIONAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051538
Enrollment
69
Registered
2023-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D25- Leiomyoma of uterus

Interventions

Intervention1: Individualised Homoeopathic Medicine: Oral Route of Administration Pill Form 30 Pill size Centesimal scale Prescribed at the start of treatment. Repetition according to follow ups. Foll

Sponsors

Bakson Homeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age 19-49 years of age. 2 Diagnosed cases of Uterine Fibroid will be included in the study. 3 Fibroid up to 10cm will be included. 4 Participants with written consent for the study will be considered. 5 Participants already on some other medications will be included in my study only after 15 days of washout period.

Exclusion criteria

Exclusion criteria: 1 Severe Uterine bleeding which can lead to hypovolemia & severe Anemia (hemoglobin 2 Pregnant and lactating females. 3 Cases with major systemic or Pathological diseases.

Design outcomes

Primary

MeasureTime frame
Expected reduction in Pictorial Blood loss Assessment Chart ScoreTimepoint: Pictorial Blood loss Assessment Chart Score will be done at baseline, 4 week, 8 weeks, 12 weeks etc—

Secondary

MeasureTime frame
NilTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Aditi Goyal

Bakson Homeopathic Medical College and Hospital

shivakavita2@gmail.com8077727749

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026